Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Donor Peripheral Stem Cell Transplant in Treating Patients With Hematolymphoid Malignancies

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborator:
National Cancer Institute (NCI)
Information provided by (Responsible Party):
Robert Lowsky, Stanford University
ClinicalTrials.gov Identifier:
NCT01523223
First received: January 27, 2012
Last updated: November 17, 2016
Last verified: July 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: December 2016
  Primary Completion Date: September 2016 (Final data collection date for primary outcome measure)